akash.verma@cenmed.com
(732) 447-1115-
P646625-10mgPCI-33380 is an irreversible and selective Bruton's Tyrosine Kinase (BTK) inhibitor (fluorescent probe).In VitroPCI-33380 bound to Btk could be detected by denaturing gel electrophoresis and fluorescent gel scanning. MCE has not independently -
O650454-5mgODN D-SL01, a class B CpG ODN (oligodeoxynucleotide), is a TLR9 agonist. ODN D-SL01 has strong immunostimulatory activity in a variety of vertebrate species and has anticancer activity. ODN D-SL01 sequence: 5'- -
O650454-1mgODN D-SL01, a class B CpG ODN (oligodeoxynucleotide), is a TLR9 agonist. ODN D-SL01 has strong immunostimulatory activity in a variety of vertebrate species and has anticancer activity. ODN D-SL01 sequence: 5'- -
O647086-5mgODN 2216 is a human-specific TLR9 (toll-like receptor 9) ligand or agonist. ODN 2216 induces high amounts of IFN-α and IFN-β . ODN 2216 induces IFN-α by pDC (plasmacytoid DC) and IL-12 (p40) production by DC (dendritic cells). ODN 2216 stimulates -
O647086-1mgODN 2216 is a human-specific TLR9 (toll-like receptor 9) ligand or agonist. ODN 2216 induces high amounts of IFN-α and IFN-β . ODN 2216 induces IFN-α by pDC (plasmacytoid DC) and IL-12 (p40) production by DC (dendritic cells). ODN 2216 stimulates -
-
-
M654764-1mlMS48107 is a potent and selective positive allosteric modulator of G protein-coupled receptor 68 (GPR68). MS48107 is selective for GPR68 over the closely related proton GPCRs, neurotransmitter transporters, and hERG ion channels. MS48107 can readily -
M651707-5mgMS4077 is an anaplastic lymphoma kinase ( ALK ) PROTAC (degrader) based on Cereblon ligand, with a K d of 37 nM for binding affinity to ALKIn VitroMS4077 effectively inhibits cancer cell proliferation. MS4077 (10 -3 -1 μM: 3 days) -
M651707-1mgMS4077 is an anaplastic lymphoma kinase ( ALK ) PROTAC (degrader) based on Cereblon ligand, with a K d of 37 nM for binding affinity to ALKIn VitroMS4077 effectively inhibits cancer cell proliferation. MS4077 (10 -3 -1 μM: 3 days) -
M650658-5mgMS417 is a selective BET-specific BRD4 inhibitor, binds to BRD4-BD1 and BRD4-BD2 with IC 50 s of 30, 46 nM and K d s of 36.1, 25.4 nM, respectively, with weak selectivity at CBP BRD ( IC 50 , 32.7 μM).In VitroMS417 is a BET-specific BRD4 inhibitor, -
M650658-50mgMS417 is a selective BET-specific BRD4 inhibitor, binds to BRD4-BD1 and BRD4-BD2 with IC 50 s of 30, 46 nM and K d s of 36.1, 25.4 nM, respectively, with weak selectivity at CBP BRD ( IC 50 , 32.7 μM).In VitroMS417 is a BET-specific BRD4 inhibitor,
